Recently, perovskite structure-based metal oxide nanomaterials and their composites opted for electrocatalyst because of its excellent conductivity, unique, and favored electronic structure. In this attempt, herein we prepared the rare earth mixed metal molybdate covered reduced graphene oxide La2(MoO4)3@rGO nanocomposites by a simple hydrothermal method for the sensitive detection of Moxifloxacin hydrochloride (MOF) in pharmaceutical and human urine samples. The various physicochemical analysis such as SEM, TEM, XRD and Raman spectroscopy confirms the successful formation of (La2(MoO4)3@rGO) nanocomposites. Furthermore, the electroanalytical performance of La2(MoO4)3@rGO modified glassy carbon electrode (La2(MoO4)3@rGO/GCE) was analyzed using the cyclic voltammetry (CV) and differential pulse voltammetry (DPV) which shows excellent results with a wide range of 1.0 × 10-8 M to 6.0 × 10-4 M and the detection limit of 2.84 × 10-9 M towards the MOF detection. Furthermore, the developed sensor expressed good selectivity, repeatability, stability and reproducibility. Finally, the real sample analysis of the developed sensor was tested in the MOF tablets and human urine samples, which shows the appreciable recoveries.
Keywords: Binary-metal oxide; Drug analysis; Electrochemical sensor; La(2)(MoO(4))(3)@rGO nanocomposites; Moxifloxacin hydrochloride sensor.
Copyright © 2022 Elsevier B.V. All rights reserved.